Epiodyne

Developing opioid medicines for pain management and opioid use disorder

placeSan Francisco, California, United States calendar_todayFounded 2016 groups4 employees language epiodyne.com

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 339 times.

YearFilings
20191
20201
20211
20222
20233
20242
20251

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon